|
1.
|
|
11 p, 1.5 MB |
Management of progressive pulmonary fibrosis associated with connective tissue disease
/
Molina-Molina, María (Institut d'Investigació Biomèdica de Bellvitge) ;
Castellvi, Ivan (Institut d'Investigació Biomèdica Sant Pau) ;
Valenzuela, Claudia (Hospital La Princesa. Servicio de Neumología) ;
Ramirez, José (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Rodríguez Portal, José Antonio (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Franquet, Tomas (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Narváez, Javier (Institut d'Investigació Biomèdica de Bellvitge) ;
Universitat Autònoma de Barcelona
Introduction: Fibrotic interstitial lung disease (ILD) is a frequent and severe complication of connective tissue disease (CTD). Areas covered: In this narrative review, we update the most relevant differential characteristics of fibrotic ILD associated with CTD (CTD-ILD) and propose a diagnostic and therapeutic approach based on a review of the articles published between 2002 and 2022 through PubMed. [...]
2022 -  10.1080/17476348.2022.2107508
Expert Review of Respiratory Medicine, Vol. 16 Núm. 7 (2022) , p. 765-774
|
|
|
2.
|
|
|
3.
|
|
13 p, 1.3 MB |
Pulse Wave Amplitude Drops Index : A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea
/
Solelhac, Geoffroy (Center for Investigation and Research in Sleep) ;
Sánchez-de-la-Torre, Manuel (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Blanchard, Margaux (Laboratoire d'Acoustique de l'Université du Mans) ;
Berger, Mathieu (Center for Investigation and Research in Sleep) ;
Hirotsu, Camila (Center for Investigation and Research in Sleep) ;
Imler, Théo (Center for Investigation and Research in Sleep) ;
Sánchez-de-la-Torre, Alicia (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Haba-Rubio, José (Center for Investigation and Research in Sleep) ;
Marchi, Nicola Andrea (Center for Investigation and Research in Sleep) ;
Bayon, Virginie (Center for Investigation and Research in Sleep) ;
Bailly, Sébastien (Université Grenoble Alpes) ;
Goupil, François (Le Mans General Hospital) ;
Waeber, Adrien (Center for Investigation and Research in Sleep) ;
Heiniger, Grégory (Center for Investigation and Research in Sleep) ;
Pigeanne, Thierry (Pôle santé des Olonnes) ;
Gracia-Lavedan, Esther (Hospital Universitari Arnau de Vilanova-Santa Maria) ;
Zapater, Andrea (Universitat de Lleida) ;
Abad Capa, Jorge (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ordax, Estrella (Hospital Universitari de Burgos) ;
Masdeu, María José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cabriada-Nuño, Valentín (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Egea, Carlos (Instituto de Investigación Sanitaria Bioaraba (Vitoria, País Basc)) ;
Van Den Broecke, Sandra (Hôpital Neuchâtelois) ;
Vollenweider, Peter (Internal Medicine) ;
Marques-Vidal, Pedro (University of Lausanne) ;
Vaucher, Julien (Internal Medicine) ;
Bernardi, Giulio (IMT School for Advanced Studies) ;
Betta, Monica (IMT School for Advanced Studies) ;
Siclari, Francesca (The Sense Innovation and Research Center) ;
Barbé, Ferran (Hospital Universitari Arnau de Vilanova-Santa Maria) ;
Gagnadoux, Frédéric (University of Angers) ;
Heinzer, Raphael (Lausanne University Hospital) ;
Universitat Autònoma de Barcelona
It is currently unclear which patients with obstructive sleep apnea (OSA) are at increased cardiovascular risk. To investigate the value of pulse wave amplitude drops (PWADs), reflecting sympathetic activations and vasoreactivity, as a biomarker of cardiovascular risk in OSA. [...]
2023 - 10.1164/rccm.202206-1223OC
American Journal of Respiratory and Critical Care Medicine, Vol. 207 (april 2023) , p. 1620-1632
|
|
|
4.
|
|
9 p, 461.9 KB |
Is asthma control more than just an absence of symptoms? : An expert consensus statement
/
Canonica, G. Walter (Humanitas University) ;
Spanevello, Antonio (Università degli Studi dell'Insubria. Dipartimento di Medicina e Chirurgia) ;
Pérez de Llano, Luis (Instituto de Investigación Sanitaria Santiago de Compostela) ;
Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Blakey, John D. (Curtin University of Technology) ;
Garcia, Gabriel (Hospital R. Rossi. Servicio de Neumología (Argentina)) ;
Inoue, Hiromasa (Kagoshima University. Department of Pulmonary Medicine) ;
Dalcolmo, Margareth (Fundação Oswaldo Cruz (Brazil)) ;
Yang, Dong (Fudan University. Zhongshan Hospital (China)) ;
Mokashi, Soniya (GSK Brentford (UK)) ;
Kurne, Abhishek (Global Medical Affairs (Singapore)) ;
Butta, Aman Kapil (GSK (Singapore)) ;
Universitat Autònoma de Barcelona
PURPOSE: Definitions and measures of asthma control used in clinical trials and in clinical practice vary considerably. There is also misalignment between patients and healthcare professionals (HCPs) in terms of understanding and managing asthma control. [...]
2022 - 10.1016/j.rmed.2022.106942
Respiratory Medicine, Vol. 202 (October 2022) , art. 106942
|
|
|
5.
|
|
|
6.
|
|
9 p, 849.5 KB |
Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain
/
Barrecheguren, Miriam (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Monteagudo, Mònica (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Miravitlles, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Flor Escriche, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Núñez, Alexa (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Osorio, Jeisson (Universitat de Barcelona) ;
Muñoz Gall, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ojanguren, Iñigo (Universitat Autònoma de Barcelona. Departament de Medicina)
The aim of this observational, retrospective study was to describe characteristics, treatment patterns, and adherence among patients with asthma who initiated multiple-inhaler triple therapy (MITT) in Catalonia, Spain. [...]
2022 - 10.1038/s41533-022-00270-2
NPJ primary care respiratory medicine, Vol. 32 (march 2022)
|
|
|
7.
|
|
|
8.
|
|
8 p, 719.6 KB |
Prevalence of modifiable factors limiting treatment efficacy of poorly controlled asthma patients : EFIMERA observational study
/
Ribó González, Paula (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Molina, Jesús (Centro de Salud Francia, Fuenlabrada) ;
Calle Rubio, Myriam (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Maiz, Luis (Hospital Universitario Ramón y Cajal (Madrid)) ;
Campo, Carlos (Orion Pharma, Madrid) ;
Rytilä, Paula (Orion Corporation Orion Pharma) ;
Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ;
Valero, Antonio (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias)
Several modifiable factors leading to poor asthma control have been described. We aimed to determine the proportion of patients with inadequate treatment, adherence to it, or critical mistakes with inhaler technique, and their impact on asthma control. [...]
2020 - 10.1038/s41533-020-00189-6
NPJ primary care respiratory medicine, Vol. 30 (july 2020)
|
|
|
9.
|
|
|
10.
|
|
10 p, 772.3 KB |
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study
/
Drake, T. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Docherty, A. B. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Harrison, E. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Quint, J. K. (National Heart and Lung Institute. Imperial College) ;
Adamali, H. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Agnew, Sarah (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Babu, S. (Queen Alexandra Hospital (Portsmouth, Regne Unit)) ;
Barber, C. M. (Northern General Hospital) ;
Barratt, S. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Bendstrup, Elisabeth (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Bianchi, S. (Northern General Hospital) ;
Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau) ;
Chaudhuri, N. (University of Manchester) ;
Chua, F. (Royal Brompton and Harefield NHS Foundation Trust) ;
Coker, R. (Hammersmith Hospital (Londres)) ;
Chang, W. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Crawshaw, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Crowley, L. E. (University of Birmingham) ;
Dosanjh, D. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Fiddler, C. A. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Forrest, I. A. (Department of Respiratory Medicine. Royal Victoria Infirmary. Newcastle upon Tyne Hospitals NHS Foundation Trust) ;
George, P. M. (Royal Brompton and Harefield NHS Foundation Trust) ;
Gibbons, M. A. (South West Peninsula ILD Network. Royal Devon & Exeter Foundation NHS Trust) ;
Groom, K. (Hammersmith Hospital (Londres)) ;
Haney, S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Hart, S. P. (Respiratory Research Group. Hull York Medical School. Castle Hill Hospital) ;
Heiden, E. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Henry, M. (Cork University Hospital) ;
Ho, L. P. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hoyles, R. K. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hutchinson, J. (King's Mill Hospital) ;
Hurley, K. (Beaumont Hospital (Dublín, Irlanda)) ;
Jones, M. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Jones, S. (Action for Pulmonary Fibrosis. Stuart House) ;
Kokosi, M. (Guys and St. Thomas' NHS Trust) ;
Kreuter, M. (Center for Interstitial and Rare Lung Diseases. Pneumology. Thoraxklinik. University of Heidelberg. German Center for Lung Research) ;
MacKay, L. S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Mahendran, S. (Kingston Hospital NHS Foundation Trust) ;
Margaritopoulos, G. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Molina Molina, Maria (Institut d'Investigació Biomèdica de Bellvitge) ;
Molyneaux, P. L. (National Heart and Lung Institute. Imperial College) ;
O'Brien, A. (University Hospital Limerick) ;
O'Reilly, K. (Department of Respiratory Medicine. Mater Misericordiae University Hospital) ;
Packham, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Parfrey, H. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Poletti, V. (Department of Diseases of the Thorax. Morgagni Hospital) ;
Porter, J. C. (UCL Respiratory. University College London. ILD Service. University College London Hospitals NHS Foundation Trust) ;
Renzoni, E. (Royal Brompton and Harefield NHS Foundation Trust) ;
Rivera-Ortega, P. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Russell, A. M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Saini, G. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Spencer, L. G. (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Stella, G. M. (Laboratory of Biochemistry and Genetics. Pneumology Unit. Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo) ;
Stone, H. (University Hospital North Midlands NHS Trust. Royal Stoke University Hospital) ;
Sturney, S. (Royal United Hospitals Bath NHS Foundation Trust) ;
Thickett, D. (University of Birmingham) ;
Thillai, M. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Wallis, T. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Ward, K. (National Heart and Lung Institute. Imperial College) ;
Wells, A. U. (Royal Brompton and Harefield NHS Foundation Trust) ;
West, A. (Guys and St. Thomas' NHS Trust) ;
Wickremasinghe, M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Woodhead, F. (Institute of Lung Health. Interstitial Lung Disease Unit. Glenfield Hospital) ;
Hearson, G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Howard, L. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Baillie, John Kenneth (Intensive Care Unit. Royal Infirmary Edinburgh) ;
Openshaw, Peter (National Heart and Lung Institute. Imperial College) ;
Semple, M. G. (Respiratory Medicine. Alder Hey Children's Hospital) ;
Stewart, I. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Jenkins, R. G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Universitat Autònoma de Barcelona
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population. [...]
2020 - 10.1164/rccm.202007-2794OC
American Journal of Respiratory and Critical Care Medicine, Vol. 202 Núm. 12 (15 2020) , p. 1656-1665
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
